[Effects of small-dose cytarabine on the course of atheromatosis in over 60 years of age patients with acute myeloblastic leukemia (description of 2 cases)].
Sokolov
A N
AN
Isaev
V G
VG
Savchenko
V G
VG
D000367:Age Factors; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D001161:Arteriosclerosis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D002455:Cell Division; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D000964:Antimetabolites, Antineoplastic; D007166:Immunosuppressive Agents; D003561:Cytarabine